Publications

Mahajan S, Lekshmi N, Dhiman P, Gupta M, Mudgal P, Yadav R, Arava S, Bhatnagar S, Wadhwa N, Kumar Y, Talukdar D, Das B, Banerjee SK*. Molecular insights into the antimicrobial and cardiometabolic functions of Lactobacillus crispatus isolated from the reproductive tract microbiota of Indian women. J Biomed Sci. 2026, 33(1):7.

Deshmukh K, Malladi N, Banerjee SK*. A flow cytometry-based assay system for the in vitro screening of anti-steatotic compounds. In vitro models, 2026, 2020, 101068 

Malladi N, Hase AD, Arava S, Yadav R, Balani JK, Borthakur A, Banerjee SK*. Empagliflozin attenuates liver steatosis and improves cardiac complications in choline-deficient high-fat diet-induced MAFLD rats. Eur J Pharmacol. 2025, 1005:178067. 

Tiwari V, Salgar S, Jorvekar SB, Kumbhar BM, Arava SK, Borkar RM, Banerjee SK*. Doxorubicin-induced phosphorylation of lamin A/C enhances DNMT1 and activates cardiomyocyte death via suppressing GATA-4 and Bcl-xL in rat heart. Biochim Biophys Acta Mol Basis Dis. 2025, 1871(3):167692. 

Das A, Lekurwale S, Mahajan S, Banerjee SK, Banerjee S. Infill-Modulated, Bioerodible, and Biocompatible Ocular Inserts for Tunable Acyclovir Release via Direct Powder Extrusion 3D Printing. Molecular Pharmaceutics. 2025, 22(10):6092-6107. 

Paul D, Talukdar D, Kapuganti RS, Gupta V, Narendrakumar L, Jana P, Kumar P, Singh J, Kumari S, Basak C, Kamboj K, Bakshi S, Lal S, Tanwar S, Kumar R, Babele P, Bajpai M, Kumar Y, Mutreja A, Mandal S, Wadhwa N, Banerjee SK, Das B. Antibiotic contamination and antimicrobial resistance dynamics in the urban sewage microbiome in India. Nat Commun. 2025, 17(1):1274. . 

Tiwari V, Alam MJ, Bhatia M, Navya M, Banerjee SK*. The structure and function of lamin A/C: Special focus on cardiomyopathy and therapeutic interventions. Life Sciences. 2024, 341:122489. 

Tariq U, Sarkar S, Malladi N, Kumar R, Bugga P, Chakraborty P, Banerjee SK*. Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast. Mol Biol Rep. 2024, 51(1):852. 

Tiwari V, Gupta P, Malladi N, Salgar S, Banerjee SK*. Doxorubicin induces phosphorylation of lamin A/C and loss of nuclear membrane integrity: A novel mechanism of cardiotoxicity. Free Radic Biol Med. 2024, 218:94-104. 

Lekurwale S, Mahajan S, Banerjee SK, Banerjee S. Systematic evaluations and integration of Assam indigenous Joha rice starch in intelligent packaging films for monitoring food freshness using beetroot extract. International Journal of Biological Macromolecules. 2024, 277:134332.

Malladi N, Lahamge D, Somwanshi BS, Tiwari V, Deshmukh K, Balani JK, Chakraborty S, Alam MJ, Banerjee SK*. Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation. Cell Signal. 2024, 121:111299. 

Das K, Sharma S, Kumar S, Mahajan S, Banerjee SK, Katiyar V. Chitosan nanoparticles and neem essential oil functionalized pullulan/gum arabic active edible biocomposites for fresh-cut guava preservation. Int J Biol Macromol. 2024, 283(Pt 1):136936. 

Kumari P, Banerjee SK, Murty US, Ravichandiran V, Mohan U. Harnessing the combined effect of antivirulence agent trans-chalcone with bactericidal curcumin against sortase A enzyme to tackle Gram-positive bacterial infections. Folia Microbiol (Praha). 2024, 69(3):639-652. 

Sontakke AD, Gupta P, Banerjee SK, Purkait MK. Chitosan-grafted folic acid decorated one-dimensional GONS: A biocompatible drug cargo for targeted co-delivery of anticancer agents. Int J Biol Macromol. 2024 Jun;271(Pt 2):132621.

Kashyap B, Saikia K, Samanta SK, Thakur D, Banerjee SK, Borah JC, Talukdar NC. Kaempferol 3-O-rutinoside from Antidesma acidum Retz. Stimulates glucose uptake through SIRT1 induction followed by GLUT4 translocation in skeletal muscle L6 cells. J Ethnopharmacol. 2023, 301:115788.

Borkar RM, Kanwal A, Raju B, Pulimamidi SS, Das AP, Agarwal SM, Banerjee SK, Srinivas R. A pharmacokinetic study to correlate the hypoglycemic effect of phlorizin in rats: Identification of metabolites as inhibitors of sodium/glucose cotransporters. J Mass Spectrom. 2023, 58(8):e4964. 

Adela R, Kasarla SS, Saquib N, Gupta SK, Bajpai S, Kumar Y, Banerjee SK*. Untargeted metabolomics reveals altered branch chain amino acids, glucose and fat metabolismcontributing to coronary artery disease among Indian diabetic patients. Molecular Omics, 2023, 19(4):321-329. 

Alam MJ, Kamboj P, Sarkar S, Gupta SK, Kasarla SS, Bajpai S, Kumari D, Bisht N, Barge SR, Kashyap B, Deka B, Bharadwaj S, Rahman S, Dutta PP, Borah JC, Talukdar NC, Kumar Y, Banerjee SK*. Untargeted metabolomics and phenotype data indicate the therapeutic and prophylactic potential of Lysimachia candida Lindl. towards high-fat high-fructose-induced metabolic syndrome in rats. Molecular Omics, 2023, 19(10):787-799

Bugga P, Alam MJ, Kumar R, Pal S, Chattopadyay N, Banerjee SK*. Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast. Cell Signal. 2022, 94:110309. 

Nizami HL, Katare PB, Prabhakar P, Adela R, Sarkar S, Arava S, Chakraborty P, Maulik SK, Banerjee SK*. Paricalcitol Attenuates Metabolic Syndrome-Associated Heart Failure through Enhanced Mitochondrial Fusion. Oxid Med Cell Longev. 2022, 2022:5554290. 

Shiekh PA, Mohammed SA, Gupta S, Das A, Meghwani H, Maulik SK, Banerjee SK, Kumar A. Oxygen releasing and antioxidant breathing cardiac patch delivering exosomes promotes heart repair after myocardial infarction. Chemical Engineering Journal, 2022, 428:132490.

Bugga P, Mohammed SA, Alam MJ, Katare P, Meghwani H, Maulik SK, Arava S, Banerjee SK*. Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress. Life Sci. 2022, 307:120862. 

Alam MJ, Uppulapu SK, Tiwari V, Varghese B, Mohammed SA, Adela R, Arava SK, Banerjee SK*. Pregestational diabetes alters cardiac structure and function of neonatal rats through developmental plasticity. Front Cardiovasc Med. 2022, 9:919293.

Sarma PP, Gurumayum N, Samanta SK, Khound P, Kumari S, Devi D, Barman J, Banerjee SK*, Devi R*. Pharmacologically active chemical composite of Musa balbisiana ameliorates oxidative stress, mitochondrial cellular respiration, and thereby metabolic dysfunction. J Food Biochem. 2022, 46(9):e14347. 

Kumari R, Ray AG, Mukherjee D, Chander V, Kar D, Kumar US, Bharadwaj P V P D, Banerjee SK, Konar A, Bandyopadhyay A. Downregulation of PTEN Promotes Autophagy via Concurrent Reduction in Apoptosis in Cardiac Hypertrophy in                PPAR α(-/-) Mice. Front Cardiovasc Med. 2022, 9:798639.

Paramesha B, Anwar S, Alam MJ, Meghwani H, Maulik SK, Arava SK, Banerjee SK*. Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress. Life Sciences, 2022, 307:120862. 

Purushotham N, Singh M, Paramesha B, Kumar V, Wakode S, Banerjee SK*, Poojary B*, Asthana S*. Design and synthesis of amino acid derivatives of substituted benzimidazoles and pyrazoles as Sirt1 inhibitors. RSC Adv., 2022, 12(7), 3809-3827. 

Tripathi R, Banerjee SK, Nirala JP, Mathur R. Simultaneous exposure to electromagnetic field from mobile phone and unimpeded fructose drinking during pre-, peri-, and post-pubertal stages perturbs the hypothalamic and hepatic regulation of energy homeostasis by early adulthood: experimental evidence. Environ Sci Pollut Res Int. 2022, 29(5):7438-7451. 

Malladi N, Johny E, Uppulapu SK, Tiwari V, Alam MD, Adela R, Banerjee SK*. Understanding the activation of platelets in diabetes and its modulation by allyl methyl sulfide, an active metabolite of garlic. Journal of Diabetes Research, 2021, 2021:1-12.

Paramesha B, Anwar S, Meghwani H, Maulik SK, Arava SK, Banerjee SK*. Sirt1 and Sirt3 activation improved cardiac function of diabetic rats via modulation of mitochondrial function. Antioxidants 2021, 10:338..

Kashyap B, Barge SR, Bharadwaj S, Deka B, Rahman S, Ghosh A, Manna P, Dutta PP, Sheikh Y, Kandimalla R, Samanta SK, Boruwa J, Saikia S, Swargiary D, Kamboj P, Tuli D, Pal U, Borah JC, Banerjee SK*, Talukdar NC*. Evaluation of therapeutic effect of Premna herbacea in diabetic rat and isoverbascoside against insulin resistance in L6 muscle cells through bioenergetics and stimulation of JNK and AKT/mTOR signaling cascade. Phytomedicine, 2021, 93: 153761. 

Kamboj P, Sarkar S, Gupta SK, Bisht N, Kumari D, Alam MJ, Barge S, Kashyap B, Deka B, Bharadwaj S, Rahman S, Dutta PP, Borah JC, Talukdar NC*, Banerjee SK*, Kumar Y*. Methanolic Extract of Lysimachia Candida Lindl. Prevents High-fat high-fructose-induced fatty liver in rats: understanding the molecular mechanism through untargeted metabolomics study. Frontiers in Pharmacology, 2021, 12: 653872. 

Swami R, Kumar Y, Chaudhari D, Katiyar SS, Kuche K, Katare PB, Banerjee SK, Jain S. pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel. Material Sci Engg C Mater Biol Appl 2021, 120:111664. 

Anwar S, Paramesha B, Meghwani H, Reddy MPK Arava SK, Banerjee SK*. Allyl methyl sulfide preserved pressure overload-induced heart failure via modulation of mitochondrial function. Biomedicine & Pharmacotherapy, 2021, 138: 111316. 

Katare PB, Nizami HL, Parmesha B, Dinda A, Banerjee SK*. Activation of toll like receptor 4 (TLR4) promotes cardiomyocyte apoptosis through SIRT2 dependent p53 deacetylation. Scientific Reports, 2020, 10: 19232.  

Mohammed SA, Parmesha B, Kumar Y, Tariq U, Sudheer AK, Banerjee SK*. Allylmethylsulfide, a sulfur compound derived from garlic, attenuates isoproterenol-induced cardiac hypertrophy in rats. Oxidative Medicine and Cellular Longevity. 2020, 2020:7856318.

Sarkar S, Bhattacharya S, Alam J, Yadav R, Banerjee SK*. Hypoxia aggravates Non-Alcoholic Fatty Liver Disease in Presence of High Fat Choline Deficient Diet: A Pilot Study. Life Sciences, 2020, 260:118404 

Aggarwal S, Banerjee SK, Talukdar NC, Yadav AK. Post-translational modification crosstalk and hotspots in sirtuin interactors implicated in cardiovascular diseases. Frontiers in Genetics, 2020, 11, 356. 

Pant A, Bag S, Saha B, Verma J, Kumar P, Banerjee S, Kumar B, Kumar Y, Desigamani A, Maiti S, Maiti TK, Banerjee SK, Bhadra RK, Koley H, Dutta S, Nair GB, Ramamurthy T, Das B. Exploiting Dynamics of Genomic Islands to Edit the Genome of Vibrio cholerae and Identify Novel Interactions Between Core and Acquired Genome. Proceedings of the National Academy of Sciences, USA, 2020, 117 (38), 23762-23773. 

Rai RC, Bagul PK, Banerjee SK*. NLRP3 inflammasome drives inflammation in high fructose fed diabetic rat liver: Effect of resveratrol and metformin. Life Sciences, 2020, 253, 117727. 

Kumari S, Katare PB, Elancheran R, Nizami HL, Parmesha B, Arava S, Sarma PP, Kumar R, Mahajan D, Kumar Y, Devi R, Banerjee SK*. Musa balbisiana fruit rich in polyphenols attenuates isoproterenol-induced cardiac hypertrophy in rats via inhibition of inflammation and oxidative stress. Oxidative Medicine and Cellular Longevity. 2020, 2020:7147498 

Mukkamala R, Kumar R, Banerjee SK*, Aidhen IS*. Synthesis of Benzyl C‐Analogues of Dapagliflozin as Potential SGLT2 Inhibitors. European Journal of Organic Chemistry, 2020, 12:1828-1839. 

Oaks Z, Jimah J, Grossman CC, Beckford M, Kelly R, Banerjee SK, Niland B, Miklossy G, Kuloglu Z, Kansu A, Lee W, Szonyi L, Banki K, Perl A. Transaldolase haplosufficiency in subjects with acetaminophen-induced liver failure. J Inherit Metab Dis. 2020, 43 (3), 496-506. 

Nizami HL, Katare P, Prabhakar P, Kumar Y, Arava SK, Chakraborty P, Maulik SK, Banerjee SK*. Vitamin D deficiency in rats causes cardiac dysfunction by inducing myocardial insulin resistance. Mol Nutr Food Res. 2019, 63(17):e1900109 

Adela R, Reddy PNC, Ghosh TS, Aggarwal S, Yadav AK, Das B, Banerjee SK*. Serum protein signature of coronary artery disease in type 2 diabetes mellitus. Journal of Translational Medicine 2019,17(1):17. 

Bagul PK, Katare PB, Bugga P, Dinda AK, Banerjee SK*. SIRT-3 Modulation by Resveratrol Improves Mitochondrial Oxidative Phosphorylation in Diabetic Heart through Deacetylation of TFAM. Cells. 2018, 7(12):235.

Galhotra P, Prabhakar P, Meghwani H, Mohammed SA, Banerjee SK, Seth S, Hote MP, Reeta KH, Ray R, Maulik SK. Beneficial effects of fenofibrate in pulmonary hypertension in rats. Mol Cell Biochem. 2018, 449(1-2):185-194.

Mattapally S, Singh M, Murthy KS, Asthana S*, Banerjee SK*. Computational modeling suggests impaired interactions between NKX2.5 and GATA4 in individuals carrying a novel pathogenic D16N NKX2.5 mutation. Oncotarget, 2018, 9(17):13713-13732. 

Katare PB, Bagul PK, Dinda AK, Banerjee SK*. Toll-Like Receptor 4 Inhibition Improves Oxidative Stress and Mitochondrial Health in Isoproterenol-induced Cardiac Hypertrophy in Rats. Frontiers in Immunology, 2017, 8:719. 

Rajasekhar Reddy P, Rani PU, Matttapally S, Banerjee SK. Ultra-small silver nanoparticles induced ROS activated Toll-pathway against Staphylococcus aureus disease in silkworm model. Mater Sci Eng C Mater Biol Appl. 2017, 77:990-1002. 

Adela R, Borkar RM, Mishra N, Vishwakarma G, Varma BA, Srinivas R*, Banerjee SK*. Lower serum vitamin D metabolites levels in relation to circulating cytokine/chemokines and metabolic hormones in pregnant women with hypertensive disorders. Frontiers in Immunology, 2017, 8:273.

Khatua TN, Borkar RM, Mohammed SA, Dinda AK, Srinivas R, Banerjee SK*. Novel Sulfur Metabolites of Garlic Attenuate Cardiac Hypertrophy and Remodeling through Induction of Na+/K+-ATPase Expression. Frontiers in Pharmacology, 2017, 8:18. 

Meghwani H, Prabhakar P, Mohammed SA, Seth S, Hote MP, Banerjee SK, Arava S, Ray R, Maulik SK. Beneficial effects of aqueous extract of stem bark of Terminalia arjuna (Roxb.), An ayurvedic drug in experimental pulmonary hypertension. J Ethnopharmacol. 2017, 197:184-194. 

Ramratnam M, Salama G, Sharma RK, Wang DW, Smith SH, Banerjee SK, Huang XN, Gifford LM, Pruce ML, Gabris BE, Saba S, Shroff SG, Ahmad F. Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy with Calcium Desensitization. PLoS One. 2016, 11(12):e0167681

Adela R, Borkar RM, Bhandi MM, Vishwakarma G, Srinivas R*, Banerjee SK*. Lower vitamin D metabolites levels were associated with increased coronary artery diseases in Indian type 2 diabetes patients. Scientific Reports 2016, 6:37593. 

Kaur G, Padiya R, Adela R, Putcha UK, Sweeya R, Reddy BR, Kumar PK, Chakravarty S, Banerjee SK*. Garlic and Resveratrol attenuate diabetic complications, loss of β-cells, pancreatic and hepatic oxidative stress in streptozotocin-induced diabetic rats.  Frontiers in Pharmacology, 2016, 7:360. 

Sultana R, Bagul PK, Katare PB, Anwar S, Padiya R, Banerjee SK*. Garlic activates SIRT-3 to prevent cardiac oxidative stress and mitochondrial dysfunction in diabetes, Life Sciences, 2016, 164:42-51. 

Kanwal A, Kasetti S, Putcha UK, Asthana S*, Banerjee SK*. Protein kinase C-mediated sodium glucose transporter 1 activation in precondition-induced cardioprotection.  Drug Design, Development and Therapy, 2016, 10:2929-2938. 

Reddy BR, Maitra S,  Jhelum P,  Kumar KP,  Bagul PK,  Kaur G,  Banerjee SK,  Kumar A,  Chakravarty S. Sirtuin 1 and 7 mediate resveratrol-induced recovery from hyper-anxiety in high-fructose-fed prediabetic rats. Journal of Biosciences, 2016, 41(3), 407-417. 

Adela R, Mohammed SA, Kanwal A, Vishwakarma G, Reddy PNC, Banerjee SK*. Elevated levels of GDF-15 is associated with increased angiotensin II in hypertensive patients with Type 2 diabetes. Personalized Medicine, 2016, 13(4):325-336. 

Khatua TN, Dinda AK, Putcha UK, Banerjee SK*. Diallyl disulfide ameliorates isoproterenol induced cardiac hypertrophy activating mitochondrial biogenesis via eNOS-Nrf2-Tfam pathway in rats. Biochemistry and Biophysics Report, 2016, 5:77–88. 

Kanwal A, Nizami HL, Mallapudi S, Putcha UK, Mohan GK, Banerjee SK*. Inhibition of SGLT1 abrogates preconditioning-induced cardioprotection against ischemia-reperfusion injury. Biochem Biophys Res Commun. 2016, 472(2):392-398. 

Borkar RM, Bhandi MM, Dubey AP, Reddy VG, Komirishetty P, Nandekar PP, Sangamwar AT, Kamal A, Banerjee SK*, Srinivas R*. An evaluation of the CYP2D6 and CYP3A4 inhibition potential of metoprolol metabolites and their contribution to drug–drug and drug–herb interaction by LC-ESI/MS/MS. Biomedical Chromatography, 2016, 30(10):1556-1572. 

Adela R, Reddy PN, Banerjee SK*. Alteration of plasma GDF-11 levels in type 2 diabetes patients with cardiovascular complications: A pilot study. J Practice Cardiovas Sci, 2015, 1 (3): 262-66. 

Bagul PK, Dinda AK, Banerjee SK*.  Effect of resveratrol on sirtuins expression and cardiac complications in diabetes. Biochem Biophys Res Commun, 2015, 468(1-2):221-227.

Bagul PK, Deepthi N, Sultana R, Banerjee SK*. Resveratrol ameliorates cardiac oxidative stress in diabetes through deacetylation of NFkB-p65 and histone 3. Journal of Nutritional Biochemistry, 2015, 26(11):1298–1307. 

Adela R, Nethi SK, Bagul PK, Barui AK, Mattapally S, Kuncha M, Patra CR, Reddy PN, Banerjee SK*. Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients. PLOS ONE. 2015,10(4):e0125270. 

Mattapally S, Nizamuddin S, Murthy KS, Thangaraj K, Banerjee SK*. c.620C>T mutation in GATA4 is associated with congenital heart disease in South India. BMC Med Genet. 2015, 16:7. 

Borkar RM, Bhandi MM, Dubey AP, Nandekar PP, Sangamwar AT, Banerjee SK*, Srinivas R*. Plasma protein binding, pharmacokinetics, tissue distribution and CYP450 biotransformation studies of fidarestat by ultra high performance liquid chromatography-high resolution mass spectrometry. J Pharm Biomed Anal. 2015, 102:386-99. 

Jallapally A, Addla D, Bagul P, Sridhar B, Banerjee SK, Kantevari S. Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors. Bioorganic & Medicinal Chemistry 2015, 23 (13), 3526-3533.

Padiya R, Choudhury D, Borkar R, Srinivas R, Pal Bhadra M, Banerjee SK*. Garlic attenuates cardiac hypertrophy and oxidative stress via activation of PI3K/AKT/NRF2-Keap1 pathway in fructose-fed diabetic rat. PLOS ONE, 2014, 9(5):e94228.

Reddy NT, Ravinder M, Bagul P, Ravikanti K,  Bagul C, Nanubolu JB, Srinivas K, Banerjee SK*,  Rao VJ*.  Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs) Eur J Med Chem., 2014, 71:53-66. 

Kalavagunta PK, Bagul PK, Jallapally A, Kantevari S, Banerjee SK*, Ravirala N*. Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers. Eur J Med Chem. 2014, 83:344-54. 

Choudhury D, Tangutur AD, Khatua TN, Saxena P, Banerjee SK*, Pal Bhadra M*. A proteomic view of isoproterenol induced cardiac hypertrophy: prohibitin identified as a potential biomarker in rats. Journal of Translational Medicine 2013, 11:130. [Impact Factor 7.5]

•  

• 90.         Addla D, Jelapally A, Kanwal A, Banerjee SK*, Kantevari S*. Design, synthesis and evaluation of novel 2-hydroxy pyrrolobenzodiazepine-5,11-dione analogues as potent Angiotensin Converting Enzyme (ACE) inhibitors. Bioorganic & Medicinal Chemistry, 2013; 21(15):4485-93. [Impact Factor 3.0]

•  

• 91.         Madabhushi S*, Chinthala N, Kanwal A, Kaur G, Banerjee SK*.  Synthesis of novel 1,2,3-triazole functionalized 2-aryl-naphtho[1,2-d]oxazole derivatives and study of their protein tyrosine phosphatase-1B (PTP1B) inhibitory activity. Medicinal Chemistry Research, 2013, 23 (4), 2062-2069. [Impact Factor 3.1]

•  

• 92.         Gupta P, Kanwal A, Putcha UA, Bulani Y, Sojitra B, Khatua TN, Kuncha M, Banerjee SK*. Cardioprotective effect of ritonavir, an antiviral drug, in isoproterenol induced myocardial necrosis: A new therapeutic implication. Journal of Translational Medicine, 2013, 11:80 [Impact Factor 7.5]

•  

• 93.         Kanwal A, Singh SP, Grover P, Banerjee SK*. Development of a Cell Based Non-radioactive Glucose Uptake Assay System for SGLT1 and SGLT2. Analytical Biochemistry, 2012, 429 (1):70-75. (Cited in Nature India, doi:10.1038/nindia. 2012. Published online 25 September 2012) [Impact Factor 2.5]

•  

• 94.         Raju B, Ramesh M, Borkar RM, Padiya R, Banerjee SK, Srinivas R*. Identification and structural characterization of in vivo metabolites of ketorolac using liquid chromatography electrospray ionization tandem mass spectrometry (LC/ESI-MS/MS)" Journal of Mass Spectrometry, 2012, 47(7): 919-931. [Impact Factor 1.7]

•  

• 95.         Bagul PK, Middela H,  Matapally S, Padiya R, Bastia T, Madhusudana K, Reddy BR, Chakravarty S, Banerjee SK*. Attenuation of Insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats. Pharmacological Research, 2012, 66(3): 260-268. [Impact Factor 10.5]

•  

• 96.         Ramesh M, Borkar RM, Padiya R, Banerjee SK*, Srinivas R*. In vivo metabolic investigation of moxifloxacin using LC/Q-TOF-ESI-MS/MS in combination with online hydrogen/deuterium (H/D) exchange technique. Rapid Communications in Mass Spectrometry, 2012, 26(16): 1817-1831. [Impact Factor 1.7]

•  

• 97.         Ravinder M, Mahendar B, Mattapally S, Hamsini KV, Reddy TN, Rohit C, Srinivas K*, Banerjee SK*, Rao VJ*. Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiestarase3 (PDE3): A target for heart failure and platelet aggregation. Bioorganic and Medicinal Chemistry Letters, 2012; 22 (18), 6010-6015. [Impact Factor 2.2]

•  

• 98.         Khatua TK, Padiya R, Karnewar S, Kuncha M, Agawane SB, Kotamraju S, Banerjee SK*. Garlic provides protection to mice heart against isoproterenol-induced oxidative damage: Role of nitric oxide. Nitric Oxide: Biology and Chemistry, 2012, 27(1):9-17. [Impact Factor 3.2]

•  

• 99.         Raju B, Ramesh M, Borkar RM, Padiya R, Banerjee SK*, Srinivas R*. Simultaneous determination of moxifloxacin and ketorolac in rat plasma using LC-ESI-MS/MS method: Application to pharmacokinetics study.  Biomedical Chromatography, 2012, 26(11):1341-7. [Impact Factor 1.7]

•  

• 100. Sojitra B,  Bulani Y, Putcha UK, Gupta P, Kanwal A, Kuncha M, Banerjee SK*. Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice. Molecular and Cellular Biochemistry,  2012, 360:61-69. [Impact Factor 3.7]

•  

• 101. Padiya R, Khatua TN, Bagul PK, Kuncha M, Banerjee SK*.  Garlic Improves Insulin Sensitivity and Associated Metabolic Syndromes in Fructose Fed Rats. Nutrition and Metabolism, 2011, 8:53. [Impact Factor 4.6]

•  

• 102. Kantevari S*, Addla D, Bagul PK, Sridhar B, Banerjee SK*. Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as Angiotensin Converting Enzyme (ACE) inhibitors. Bioorganic & Medicinal Chemistry, 2011, 19(16): 4772-4781. [Impact Factor 3.0]

•  

• 103. Banerjee SK, Wang DW, Alzamora R, Huang XN, Pastor-Soler NM, Hallows KR, McGaffin KR, Ahmad F. SGLT1, a Novel Cardiac Glucose Transporter, Mediates Increased Glucose Uptake in PRKAG2 Cardiomyopathy. J Mol Cell Cardiol. 2010, 49(4):683-92.  [Impact Factor 4.7]

•  

• 104. Banerjee SK, McGaffin KR, Huang XN, Ahmad F. Activation of cardiac hypertrophic signaling pathways in a transgenic mouse with the human PRKAG2 Thr400Asn mutation. Biochim Biophys Acta: Mol Basis of Dis 2010;1802(2):284-91. [Impact Factor 4.2]

•  

• 105. Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res. 2009; 84(1):111-118. [Impact Factor 13.3]

•  

• 106. Hanczko R, Fernandez DR, Doherty E, Qian Y, Vas G, Niland B, Telarico T, Garba A, Banerjee SK, Middleton FA, Barrett D, Barcza M, Banki K, Landas SK, Perl A. Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest. 2009; 119(6):1546-1557. [Impact Factor: 13.6]

•  

• 107. Fernandez DR, Telarico T, Bonilla E, Li Q, Banerjee SK, Middleton FA, Phillips PE,Crow MK, Oess S, Muller-Esterl W, Perl A. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. Journal of Immunology. 2009;182(4):2063-2073.  [Impact Factor: 3.4]

•  

• 108. Ahmad F, Banerjee SK, Lage ML, Huang XN, Smith SH, Saba S, Rager J, Conner DA, Janczewski AM, Tobita K, Tinney JP, Moskowitz IP, Perez-Atayde AR, Keller BB, Mathier MA,Shroff SG, Seidman CE, Seidman JG. The role of cardiac troponin T quantity and function in cardiac development and dilated cardiomyopathy. PLoS ONE 2008;3(7):e2642.  [Impact Factor: 2.6]

•  

• 109. Qian Y, Banerjee SK, Grossman CE, Wendy Amidon1, Nagy G, Barcza M, Niland B, Karp DR, Middleton FA, Banki K, Perl A. Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homeostasis, and apoptosis signal processing. Biochemical Journal. 2008; 415(1):123-34.  [Impact Factor: 4.4]

•  

• 110. Banerjee SK, Ramani R, Saba S, Rager J, Tian R, Mathier MA, Ahmad F. A PRKAG2 mutation causes biphasic changes in myocardial AMPK activity and does not protect against ischemia. Biochem. Biophys. Res. Commun. 2007 Aug 24;360(2):381-7.  [Impact Factor: 2.2]

•  

• 111. Perl A, Qian Y, Chohan KR, Shirley CR, Amidon W, Banerjee SK, Middleton FA, Conkrite KL, Barcza M, Gonchoroff N, Suarez SS, Banki K. Transaldolase is essential for maintenance of the mitochondrial transmembrane potential and fertility of spermatozoa. Proc Natl Acad Sci U SA. 2006;103(40):14813-8. [Impact Factor: 9.1]

•  

• 112. Devi R, Banerjee SK, Sood S, Dinda AK, Maulik SK. Extract from Clerodendron colebrookianum Walp protects rat heart against oxidative stress induced by ischemic-reperfusion injury (IRI). Life Sciences. 2005; 77(24):2999-3009.  [Impact Factor: 5.1]

•  

• 113. Gauthaman K, Banerjee SK, Dinda AK, Ghosh CC, Maulik SK. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein.  Journal of Ethnopharmacology. 2005; 96(3):403-409.  [Impact Factor: 5.4]

•  

• 114. Rajak S, Banerjee SK, Sood S, Dinda AK, Gupta YK, Gupta SK and Maulik SK. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytotherapy Research. 2004;18(1):54-60. [Impact Factor: 6.3]

•  

• 115. Banerjee SK, Sood S, Dinda AK, Das TK, Manchanda SC, Maulik SK. Chronic oral administration of raw garlic protects against isoproterenol-induced myocardial necrosis in rat. Comp Biochem Physiol C Toxicol Pharmacol. 2003; 136(4):377-386.  [Impact Factor :4.3]

•  

• 116. Devi Rajlakshmi, Banerjee SK, Sood S, Maulik SK. In-vitro and in-vivo antioxidant activity of different extracts of the leaves of Clerodendron colebrookianum Walp,  (Nefafu). Journal of Pharmacy and Pharmacology. 2003, 55(12):1681-1686. [Impact Factor 3.2]

•  

• 117. Mukherjee S., Banerjee S.K., Maulik M., Dinda A.K., Talwar K.K., Maulik S.K. Garlic protects against acute adriamycin induced cardiotoxicity: Role of endogenous antioxidants and inhibition of TNF--a expression. BMC Pharmacology. 2003, 3(1):16. [Impact Factor 2.4]

•  

• 118.     Banerjee SK, Dinda AK, Manchanda SC, Maulik SK. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacology. 2002, 2:16.  [Impact Factor 2.4]

•  

• 119. Banerjee SK., Maulik M., Mancahanda SC., Dinda AK., Gupta SK., Maulik SK. Dose dependent induction of endogenous antioxidant by chronic administration of garlic in rat heart. Life Sciences 2002, 70 (13): 1509-1518.  [Impact Factor: 5.1]

•  

• 120. Banerjee SK, Maulik M., Manchanda SC, Dinda AK, Das TK and Maulik SK.  Garlic induced alteration in rat liver and kidney morphology and associated changes in endogenous antioxidant status. Food and Chemical Toxicology, 2001, 39(8):793-797.  [Impact Factor: 3.5]

•  

• 121. Das AK, Mandal SC, Banerjee SK, Sinha S, Saha BP and Pal M.  Studies on the hypoglycemic activity of Punica granatum seed in streptozotocin induced diabetic rats. Phytotherapy Research, 2001, 15 (7): 628-629. [Impact Factor: 6.3]

•  

• 122. Bhakta T, Banerjee SK, Maity TK, Mandal SC, Saha BP and Pal M. Hepatoprotective activity of Cassia fistula leaf extract. Phytomedicine. 2001, 8(3): 220-224.  [Impact Factor: 8.3]

•  

• 123. Bhakta T, Mukherjee PK, Mukherjee K, Banerjee SK, Mandal SC, Maity TK, Pal M and Saha BP. Evaluation of hepatoprotective activity of Cassia fistula leaf extract. Journal of Ethnopharmacology, 1999, 66:277-282. [Impact Factor: 5.4] 

•  

• 124. Das AK, Mandal SC, Banerjee SK, Sinha S, Das J, Saha BP and Pal M. Studies on antidiarrhoeal activity of Punica granatum seed extract in rat. Journal of Ethnopharmacology. 1999, 68:205-208. [Impact Factor: 5.4]

•  

• Review articles

•  

• 125.     Mahajan S, Anagha NK, Banerjee SK*. Recent advances of microbial medicine to prevent and treat cardiovascular disease. Progress in Molecular Biology and Translational Science, 2026, 220, 305-337. [Impact Factor: NA]

•  

• 126. Mahajan S, Malladi N, Banerjee SK*. Future potential therapeutics to treat MASH. Drug Discov Today. 2025 Sep;30(9):104451. [Impact Factor: 7.5]

•  

• 127. Chakraborty S, Tiwari V, Banerjee SK*. Targeting the non-neuronal cholinergic machinery: A novel approach to mitigate cardiac aging. Ageing Res Rev. 2025 Jul;109:102782. [Impact Factor :12.4]

•  

• 128. Tiwari V, Alam MJ, Bhatia M, Navya M, Banerjee SK*. The structure and function of lamin A/C: Special focus on cardiomyopathy and therapeutic interventions. Life Sci. 2024 Mar 15;341:122489. [Impact Factor: 5.1]

•  

• 129. Malladi N, Alam MJ, Maulik SK, Banerjee SK*. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics. Prostaglandins Other Lipid Mediat. 2023 Jul 20;169:106766. [Impact Factor :2.5]

•  

• 130. Tiwari V, Banerjee SK*. Therapeutic Potential of HDAC Inhibitors in the Treatment of Cardiac Diseases: A Short Review. Curr Drug Targets. 2023;24(9):718-727. [Impact Factor :2.5]

•  

•  

• 131.     Alam MJ, Puppala V, Uppulapu SK, Das B, Banerjee SK*. Human microbiome and cardiovascular diseases. Prog Mol Biol Transl Sci. 2022;192(1):231-279. [Impact Factor: NA]

•  

• 132. Uppulapu SK, Alam MJ, Kumar S, Banerjee SK*. Indazole and its Derivatives in Cardiovascular Diseases: Overview, Current Scenario, and Future Perspectives. Curr Top Med Chem. 2022;22(14):1177-1188. [Impact Factor: 3.3]

•  

• 133. Purohit A, Alam MJ, Kandiyal B, Shalimar, Das B, Banerjee SK*. Gut microbiome and non-alcoholic fatty liver disease. Prog Mol Biol Transl Sci. 2022;191(1):187-206. [Impact Factor NA]

•  

• 134. Yadav AK, Banerjee SK, Das B, Chaudhary K. System biology and omics approaches for  understanding complex disease biology. Front Genet. 2022 Apr 12;13:896818. [Impact Factor: 2.8]

•  

• 135. Kumari P, Bowmik S, Paul SK, Biswas B, Banerjee SK, Murty US, Ravichandiran V, Mohan U. Sortase A: A chemoenzymatic approach for the labeling of cell surfaces. Biotechnol Bioeng. 2021 Dec;118(12):4577-4589. [Impact Factor: 3.6]

•  

• 136. Tariq U, Uppulapu SK, Banerjee SK*. Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure. Current Drug Target, 2021;22(13):1568-1576. [Impact Factor: 2.5]

•  

• 137. Kamboj P, Talukdar NC, Banerjee SK*. Therapeutic Benefit of Dillenia indica in Diabetes and Its Associated Complications. J Diabetes Res. 2019 Nov 23;2019:4632491. [Impact Factor: 3.4]

•  

• 138. Senapati T, Kothidar A, Banerjee SK, DAS B. Insights into the gastrointestinal tract microbiomes of Indian population. J Biosci. 2019 Oct;44(5). pii: 113. [Impact Factor: 1.9]

•  

• 139. Orhan I, Azzini E, Martorell M, Ahmad Z, Zucca P, Armstrong L, Martins N, Rigano D, Banerjee SK, Oluwaseun AC, Salehi B, Mohammed SA, Sharopov F, Selamoglu Z, Sureda A. Allicin and Health: A comprehensive review. Trends in Food Science and Technology, 2019, 86: 502-516. [Impact Factor: 15.4]

•  

• 140.     Sarkar S, Das B*, Banerjee SK*. Insights into the human gut microbiome and cardiovascular diseases. J Prac Cardiovac Sci, 2018, 4 (1): 10-14. [Impact Factor: 0.6].

•  

• 141.     Katare P, Banerjee SK*. Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario. Current Topics in Medicinal Chemistry, 2016, 16(19):2189-200. [Impact Factor 3.3]

•  

• 142.     Adela R, Banerjee SK*. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. J Diabetes Res. 2015;2015:490842. [Impact Factor:3.4]

•  

• 143.     Bagul PK, Banerjee SK*. Application of resveratrol in diabetes: rationale, strategies and challenges. Current Molecular Medicine. 2015;15(4):312-30. [Impact Factor :2.5]

•  

• 144. Khatua TN, Adela R, Banerjee SK*. Garlic and cardioprotection: Insights into molecular mechanisms. Canadian Journal of Physiology and Pharmacology, 2013; 91(6):448-58. [Impact Factor: 1.4]

•  

• 145. Bagul P, Banerjee SK*. Insulin Resistance, Oxidative Stress and Cardiovascular Complications: Role of Sirtuins. Current Pharmaceutical Design, 2013;19(32):5663-77. [Impact Factor: 2.8]

•  

• 146. Padiya R, Banerjee SK*. Garlic as an Anti-diabetic Agent: Recent Progress and Patent Reviews. Recent Patents on Food, Nutrition & Agriculture, 2013;5(2):105-27. [Impact Factor:0.37]

•  

• 147. Kanwal A, Banerjee SK*. Patent review of sodium glucose co-transporter (SGLT) inhibitors: A novel target for diabetes. Pharmaceutical Patent Analyst, 2013, 2(1):77-91. [Impact Factor 2.1]

•  

• 148.     Mattapally S, Banerjee SK*. Nitric oxide: redox balance, protein modification and therapeutic potential in cardiovascular system. The IIOAB Journal, 2011, 2(6): 29-38. [Impact Factor 0.0]

•  

• 149. Banerjee SK, Mukherjee PK and Maulik SK. The antioxidant effect of garlic. The good, the bad and the ugly. Phytotherapy Research 2003, 17(2): 1-10. [Impact Factor :6.3]

•  

• 150. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: a review. Nutrition Journal 2002, 1:4  [Impact Factor:3.8]

•